Medication info
Esome 20mg (Esomeprazole Magnesium Trihydrate)

Esome 20mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Trihydrate›22.25mg / 1 tablet
Manufacturer / importer
LNC Bio Co., Ltd.
Appearance
Pale pink round film-coated tablet
Packaging
28 tablets/box [(14 tablets/Alu-Alu × 2)], 30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202003714 · Approved 2020.05.21 · Insurance code 060500810

Summary

Main use
Treatment and prevention of gastric disorders caused by excess stomach acid (including reflux), ulcers and Helicobacter pylori infection, and gastrointestinal disorders caused by anti-inflammatory analgesics
Who uses it
Adults · Children
Adult dosage
This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, take it for an additional 4 weeks. 20 mg once daily 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. Adults may take 20 mg once daily as needed. For patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug therapy, as-needed administration is not recommended for controlling recurring symptoms. Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Clinical studies longer than 4 weeks have not been conducted. 20 mg once daily. The treatment period is 4∼8 weeks. 20 mg once daily. The recommended initial dose is 40 mg twice daily. Subsequent doses should be adjusted individually, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses of 80 mg or more daily should be divided into 2 doses. Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection. No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal failure. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. No dose adjustment is necessary.
Children's dosage
Adolescents aged 12 years and older — Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, take it for an additional 4 weeks. Adolescents aged 12 years and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Adolescents aged 12 years and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. Children under 12 years of age — There is no experience with administering this medicine to children under 12 years of age.

Ingredients

Manufacturer
LNC Bio Co., Ltd.

Efficacy & effects

Treatment and prevention of gastric disorders caused by excess stomach acid (including reflux), ulcers and Helicobacter pylori infection, and gastrointestinal disorders caused by anti-inflammatory analgesics

  • Gastroesophageal reflux disease
  • reflux esophagitis
  • esophagitis
  • duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal symptoms
  • pain
  • discomfort
  • burning sensation
  • gastric ulcers
  • duodenal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used for the treatment of gastroesophageal reflux disease, especially reflux esophagitis, and for long-term maintenance therapy to prevent recurrence in esophagitis patients. It is also effective in alleviating symptoms of gastroesophageal reflux disease without esophagitis. It is used in combination with antibiotics for the eradication of Helicobacter pylori and helps in the treatment and prevention of recurrence of duodenal and peptic ulcers caused by H. pylori. It is also effective in treating upper gastrointestinal symptoms and gastric ulcers associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs), as well as preventing gastric and duodenal ulcers. It is widely used in the treatment of Zollinger-Ellison syndrome and prevention and maintenance therapy of rebleeding from gastric or duodenal ulcers. This medication is used for the treatment of various gastrointestinal-related diseases and symptom relief.

Dosage and Administration

Adult dosage

This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, take it for an additional 4 weeks. 20 mg once daily 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. Adults may take 20 mg once daily as needed. For patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug therapy, as-needed administration is not recommended for controlling recurring symptoms. Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Clinical studies longer than 4 weeks have not been conducted. 20 mg once daily. The treatment period is 4∼8 weeks. 20 mg once daily. The recommended initial dose is 40 mg twice daily. Subsequent doses should be adjusted individually, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses of 80 mg or more daily should be divided into 2 doses. Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection. No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal failure. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. No dose adjustment is necessary.

Children's dosage

Adolescents aged 12 years and older — Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, take it for an additional 4 weeks. Adolescents aged 12 years and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Adolescents aged 12 years and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. Children under 12 years of age — There is no experience with administering this medicine to children under 12 years of age.

Precautions

This medication should not be administered to patients who are hypersensitive to certain components or have previously experienced allergic reactions. It is also safe to avoid administration in patients currently taking certain antibiotics or antivirals, those with a history of myocardial infarction, and nursing women. This medication contains Yellow No. 5, so those allergic to this component should use it with caution. During treatment, various side effects such as headaches, dizziness, dyspepsia, skin rashes, and muscle pain may occur, so if any unusual symptoms arise, consult a doctor immediately. Especially with long-term use, there are risks of hypomagnesemia, increased fracture risk, and gastrointestinal infections, so regular monitoring is necessary. This medication may interact with other drugs, so it is essential to inform healthcare professionals about any concomitant medications, and dose adjustment or discontinuation may be necessary with certain medications. Pregnant or nursing women should consult a physician before taking this medication. In cases of overdose, there is no specific antidote, so it is crucial to go to the hospital immediately for appropriate treatment, and it is important to keep it out of reach of children. Also, transferring the medication to other containers is not advisable for maintaining quality.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylaxis, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucination, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, eosinophilia with systemic symptoms drug reaction, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, hepatic dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatic polymyalgia, anorexia, apathy, increased appetite, confusion, exacerbation of depression, hypertonicity, sensory impairment, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, visual field loss, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, dysosmia, ageusia, gustatory distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, voiding frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyps, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is important to maintain the storage temperature between 1 and 30 degrees Celsius to preserve the medication's effectiveness.

Appearance and packaging

Appearance

Pale pink round film-coated tablet

Package unit

28 tablets/box [(14 tablets/Alu-Alu × 2)], 30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.